🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Mulligan Mobilization With or Without Niel Asher Technique in Patients With Adhesive Capsulitis

RecruitingNAAges 40 Years - 60 YearsAllRiphah International University
NCT06985836 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Adhesive capsulitis is a prevalent condition characterized by pain and stiffness in shoulder joint and surrounding muscles shows decrease range and strength in patients with adhesive capsulitis. This study aims to determine the effect of mulligan mobilization with or without Niel Asher technique on pain, range of motion and disability in patients with adhesive capsulitis. This study will be a randomized controlled trial and will be conducted in Ibne-siena Hospital Multan and Multicare physiotherapy clinic. Non-probability convenience sampling will be used to collect the data. Sample size of subjects with age group between 40 to 60 years will be taken. Data will be collected from the patients having present complaint of adhesive capsulitis. Outcome measures used will be Numeric pain rating scale (NPRS) for shoulder pain and SPADI for shoulder disability and Universal Goniometer (GU) for R

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age group 40-60 year * Both gender male and female * Stage 2 primary adhesive capsulitis with capsular pattern of restriction (rotation\>abduction\>flexion) * Pain in shoulder should be ≤7 on NPRS * Patient is willing to perform. Exclusion Criteria: * • Diabetes * Malignancy * Infection * Arthoplasty * Pregnancy * Neurological disorders * Fracture * Thyroid diseases
💊

What it tests

  • Mulligan Mobilization and Niel Asher technique
  • Mulligan Mobilization and Conventional physiotherapy.
📍

Where

1 site
Ibne Siena hospital Multan.
Multan Khurd, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy